JPRN-UMIN000017093已完成未知
The combination therapy of prednisolone and cyclosporine for initial onset of Vogt-Koyanagi-Harada disease. - PSL/CYA combination therapy for VKH disease
niversity of Tokyo Graduate School of Medicine0 个研究点目标入组 120 人开始时间: 2015年4月10日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 70years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Renal dysfunction 2.Immunosuppressant treatment including steroid 3.Immunocompromised condition 4.Females who are pregnant or lactating patients or who are suspicious of pregnant 5.Malignant neoplasm 6.Ontraocular surgery (except for cataract surgery) or glaucoma surgery previously,or speculate to be required in the periods of this study 7.Investigator declare a subject ineligible for any sound reasons
研究者
相似试验
已完成
不适用
The combination therapy of prednisolone and cyclosporine for initial onset of Vogt-Koyanagi- Harada disease.Vogt-Koyanagi- Harada diseaseJPRN-UMIN000013373Hokkaido University Graduate School of Medicine120
招募中
不适用
The combination therapy of prednisolone and cyclosporine for initial onset of Vogt-Koyanagi-Harada disease.Vogt-Koyanagi-Harada diseaseJPRN-UMIN000014041Yamaguchi University Hospital120
进行中（未招募）
3 期
PSL/CYA therapy for early onset of VKH diseaseVogt-Koyanagi-Harada diseaseJPRN-jRCTs011180031amba Kenichi120
未知
不适用
A combination of cyclosporine and prednisolone and a combination of methylprednisolone, cyclosporine and prednisolone for steroid-resistant nephrotic syndrome in children: A randomized controlled studySteroid-resistant nephrotic syndrome in childrenJPRN-C000000007Japanese Study Group of Kidney Disease in Children90
已完成
不适用
Prednisolone only and a combination of prednisolone and mizoribine for primary nephrotic syndrome relapsed within six mounths after first onset in children: A randomized controlled trial of efficacy and safety (JSRDC06)Steroid-sensitive nephrotic syndromeJPRN-C000000379Japanese Study Group of Renal Disease in Children(JSRDC)50